Cannabinoids in trigeminal neuralgia

Trigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums. The authors present a clinical case involving a 46-year-old patient with trigeminal neuralgi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Antonino Genovese, Antonella Calabrò, Davide Capone
Formato:	article
Lenguaje:	EN IT
Publicado:	Publiediting 2021
Materias:	trigeminal neuralgia cannabinoids medical cannabis chronic pain analgesia Anesthesiology RD78.3-87.3 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/cab901b8cdfd421fb0920a16a27798ce
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cab901b8cdfd421fb0920a16a27798ce
record_format	dspace
spelling	oai:doaj.org-article:cab901b8cdfd421fb0920a16a27798ce2021-11-21T11:39:31ZCannabinoids in trigeminal neuralgia1593-23542385-0744https://doaj.org/article/cab901b8cdfd421fb0920a16a27798ce2021-09-01T00:00:00Zhttps://www.pathos-journal.com/2021_2_218.htmlhttps://doaj.org/toc/1593-2354https://doaj.org/toc/2385-0744Trigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums. The authors present a clinical case involving a 46-year-old patient with trigeminal neuralgia; in this study, cannabinoid treatment (19% THC; <1% CBD) showed good pain relief.Antonino GenoveseAntonella CalabròDavide CaponePublieditingarticletrigeminal neuralgiacannabinoidsmedical cannabischronic painanalgesiaAnesthesiologyRD78.3-87.3Therapeutics. PharmacologyRM1-950ENITPathos, Vol 28, Iss 2 (2021)
institution	DOAJ
collection	DOAJ
language	EN IT
topic	trigeminal neuralgia cannabinoids medical cannabis chronic pain analgesia Anesthesiology RD78.3-87.3 Therapeutics. Pharmacology RM1-950
spellingShingle	trigeminal neuralgia cannabinoids medical cannabis chronic pain analgesia Anesthesiology RD78.3-87.3 Therapeutics. Pharmacology RM1-950 Antonino Genovese Antonella Calabrò Davide Capone Cannabinoids in trigeminal neuralgia
description	Trigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums. The authors present a clinical case involving a 46-year-old patient with trigeminal neuralgia; in this study, cannabinoid treatment (19% THC; <1% CBD) showed good pain relief.
format	article
author	Antonino Genovese Antonella Calabrò Davide Capone
author_facet	Antonino Genovese Antonella Calabrò Davide Capone
author_sort	Antonino Genovese
title	Cannabinoids in trigeminal neuralgia
title_short	Cannabinoids in trigeminal neuralgia
title_full	Cannabinoids in trigeminal neuralgia
title_fullStr	Cannabinoids in trigeminal neuralgia
title_full_unstemmed	Cannabinoids in trigeminal neuralgia
title_sort	cannabinoids in trigeminal neuralgia
publisher	Publiediting
publishDate	2021
url	https://doaj.org/article/cab901b8cdfd421fb0920a16a27798ce
work_keys_str_mv	AT antoninogenovese cannabinoidsintrigeminalneuralgia AT antonellacalabro cannabinoidsintrigeminalneuralgia AT davidecapone cannabinoidsintrigeminalneuralgia
_version_	1718419390165155840

Cannabinoids in trigeminal neuralgia

Ejemplares similares